Welcome to our dedicated page for Justera Health news (Ticker: SCRSF), a resource for investors and traders seeking the latest updates and insights on Justera Health stock.
Justera Health Ltd. (CSE: VTAL, OTC: SCRSF) is a Canadian health and wellness company whose news flow reflects activity across healthcare services, nutritional supplements, wellness experiences, cannabis products, and corporate finance. Established in 2020, the company regularly issues updates on its subsidiaries, capital structure decisions, and governance changes.
News about Justera often highlights developments in its personalized healthcare and wellness operations, including IV Vitamin Therapy services, the Naturevan Nutrition premium supplement brand, and the Juillet Wellness spa business, which offers registered massage therapy, acupuncture, and wellness-focused retail stores in Vancouver. These updates can provide context on how the company is positioning its health and wellness offerings.
A significant portion of Justera’s recent news has focused on its cannabis-related activities. The company announced the completion of its acquisition of Port North, a solventless cannabis extract brand operating from Port Elgin, Ontario, and has reported on Port North’s expansion into facilities operated by Lune Rise Farms. These releases describe Port North’s emphasis on pure, 100% solventless cannabis extracts and a product lineup that includes Hand Rolled Ice Water Hash, strain-specific full-spectrum gummies, and full-spectrum live rosin vapes.
Investors following SCRSF news will also see announcements on debt settlement transactions, RSU grants and vesting schedule changes under the company’s omnibus incentive plan, and governance items such as management changes and director resignations. In addition, Justera has reported a non-binding letter of intent to acquire Babbage Mining Co., a proof-of-stake mining operation, which the company states could enable it to accept certain crypto digital currencies as payment if the transaction is completed.
This news page aggregates these corporate, operational, and transaction-related updates in one place, allowing readers to review Justera Health’s disclosed activities and strategic moves over time.
Justera Health (OTC:SCRSF) announced a change in its external auditors from SHIM & Associates LLP to Horizon Assurance LLP, effective August 7, 2025. The former auditor resigned on June 2, 2025. Due to this transition, the company's audited annual financial statements, originally due July 30, 2025, have been delayed.
The company confirmed there were no modified opinions in the former auditor's reports for the two most recent financial years. The change was approved by both the board of directors and audit committee, with no reportable events occurring during the former auditor's tenure. Required documentation has been filed on SEDAR in accordance with National Instrument 51-102.
Justera Health announced two significant corporate changes. First, the company reported the resignation of Richard Yoon from its Board of Directors, effective March 28, 2025. Yoon stepped down to pursue other professional opportunities.
The Board will continue under the leadership of Joshua Herman and Young Cho Lee, who remain committed to advancing the company's strategic initiatives and optimizing its asset portfolio value.
Additionally, Justera has modified its fiscal year end from December 31 to March 31. This change aims to better align the company's reporting cycle with its operational and strategic planning objectives.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has signed a non-binding LOI to acquire 100% of Babbage Mining Co., a proof-of-stake mining operation with Coinbase custodian accounts. The proposed transaction involves issuing 12,000,000 common shares at $0.02 per share, with a 1% royalty, subject to regulatory approvals.
The acquisition will enable Justera to accept cryptocurrencies like Bitcoin, Ethereum, and Solana as payment methods. The transaction is arm's length and won't constitute a fundamental change. The consideration shares may be subject to a 4-month hold period. The deal completion depends on corporate and regulatory approvals and entering into a definitive agreement.
Justera Health, which operates in healthcare, pharmaceuticals, and wellness sectors, recently expanded into cannabis through the Port North brand acquisition.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has announced a revision to the vesting schedule of Restricted Share Units (RSUs) granted on November 8, 2024, to comply with CSE policy 6.1(4). Under the new vesting schedule, 50% of RSUs will vest on March 9, 2025 (four months plus one day from issuance), and the remaining 50% will vest on May 8, 2025 (six months from issuance).
Port North, a subsidiary of Justera Health, has expanded operations by partnering with Lune Rise Farms in South Bruce County, Ontario. The collaboration aims to enhance production of premium solventless cannabis products for recreational and therapeutic markets. Lune Rise Farms specializes in sun-grown cultivars and premium fresh frozen products, while Port North is known for its proprietary solventless extraction methods. The partnership will support the expansion of Port North's product line, which includes Hand Rolled Ice Water Hash, Strain-Specific Full-Spectrum Gummies, and Full-Spectrum Live Rosin Vapes.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announces leadership changes as Young Cho Lee steps down as CEO effective November 15, 2024. The company's Director, Joshua Herman, has been appointed as the new Chief Executive Officer. Herman, bringing extensive public company experience, will focus on driving the company's growth and delivering value to stakeholders.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announced the approval of 23 million restricted share units (RSUs) under its omnibus incentive plan. The RSUs, granted to employees, directors, and consultants, will vest in three stages: 50% immediately, 25% after three months, and the remaining 25% after six months from issuance. This initiative aims to retain skilled personnel and align their interests with shareholders.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has closed a previously announced debt settlement agreement. The company settled a $355,570 debt owed to a non-arm's-length creditor by issuing 7,111,400 Units at a deemed price of C$0.05 per Unit. Each Unit comprises one Common share and one Share Purchase Warrant, exercisable at $0.05 per share for an additional Common share, valid for 5 years. The warrants include an acceleration clause for forced exercise if the company's shares trade at or above $0.10 for 5 consecutive trading days on the CSE. The issued securities will be subject to a four-month and one-day hold period from the date of issuance.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has successfully completed the acquisition of Port North Extracts Inc., a popular cannabis brand known for its solventless extraction techniques. The transaction, closed on October 16, 2024, involved exchanging 80,000,000 Justera common shares for 100% of Port North's outstanding shares at a deemed value of $0.02 per share. Additionally, Port North warrants were exchanged for Justera warrants with an exercise price of $0.05 per share.
The acquisition aims to diversify Justera's product offerings and expand its footprint in the cannabis sector. Joshua Herman, Port North's CEO, has joined Justera's Board of Directors. Justera plans to leverage Port North's expertise and market presence to drive expansion and profitability in the coming months.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has announced a debt settlement agreement to settle an outstanding debt of approximately C$355,570. The company will issue 7,111,400 Units at a deemed price of C$0.05 per Unit to a non-arm's-length creditor. Each Unit consists of one Common share and one Share Purchase Warrant exercisable at $0.05 per share for an additional Common share, valid for 5 years.
The warrants include an acceleration clause for forced exercise if the company's shares trade at or above $0.10 for 5 consecutive trading days. The Board believes this settlement preserves cash for ongoing operations. The transaction is subject to a 4-month and 1-day hold period from issuance. As certain directors are insiders of the creditor, this is considered a "related party transaction" under MI 61-101, but the company intends to rely on exemptions from valuation and minority shareholder approval requirements.